Cocaine induces oxidative damage to skin via xanthine oxidase and nitric oxide synthase

Journal of Dermatological Science

Volumn 58, Issue 2, 2010, Pages 105-112

  Portugal Cohen, Meital ^a   Numa, Ran ^a   Yaka, Rami ^a   Kohen, Ron ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Cocaine; Inducible nitric oxide synthase; Oxidative stress; Skin; Xanthine oxidase

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; COCAINE; GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; PEROXIDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; XANTHINE OXIDASE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MALE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKIN DEFECT;

ANIMALS; CELL LINE, TUMOR; COCAINE; DOPAMINE UPTAKE INHIBITORS; GLUTATHIONE; HUMANS; KERATINOCYTES; MALE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PEROXIDES; RATS; REACTIVE OXYGEN SPECIES; SKIN; SUPEROXIDES; XANTHINE OXIDASE;

EID: 77952237900     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.03.010     Document Type: Article

References (76)

1. Bashkatova V., Meunier J., Maurice T., Vanin A. Memory impairments and oxidative stress in the hippocampus of in-utero cocaine-exposed rats. Neuroreport 2005, 16:1217-1221.
2. Numa R., Kohen R., Poltyrev T., Yaka R. Tempol diminishes cocaine-induced oxidative damage and attenuates the development and expression of behavioral sensitization. Neuroscience 2008, 155:649-658.
3. Fan L., Sawbridge D., George V., Teng L., Bailey A., Kitchen I., et al. Chronic cocaine-induced cardiac oxidative stress and mitogen-activated protein kinase activation: the role of Nox2 oxidase. J Pharmacol Exp Ther 2009, 328:99-106.
4. Moritz F., Monteil C., Mulder P., Derumeaux G., Bizet C., Renet S., et al. Prolonged cardiac dysfunction after withdrawal of chronic cocaine exposure in rats. J Cardiovasc Pharmacol 2003, 42:642-647.
5. Boelsterli U.A., Goldlin C. Biomechanisms of cocaine-induced hepatocyte injury mediated by the formation of reactive metabolites. Arch Toxicol 1991, 65:351-360.
6. Diez-Fernandez C., Zaragoza A., Alvarez A.M., Cascales M. Cocaine cytotoxicity in hepatocyte cultures from phenobarbital-induced rats: involvement of reactive oxygen species and expression of antioxidant defense systems. Biochem Pharmacol 1999, 58:797-805.
7. Pacifici R., Fiaschi A.I., Micheli L., Centini F., Giorgi G., Zuccaro P., et al. Immunosuppression and oxidative stress induced by acute and chronic exposure to cocaine in rat. Int Immunopharmacol 2003, 3:581-592.
8. Kloss M.W., Rosen G.M., Rauckman E.J. Cocaine-mediated hepatotoxicity. A critical review. Biochem Pharmacol 1984, 33:169-173.
9. Kloss M.W., Rosen G.M., Rauckman E.J. N-demethylation of cocaine to norcocaine. Evidence for participation by cytochrome P-450 and FAD-containing monooxygenase. Mol Pharmacol 1983, 23:482-485.
10. LeDuc B.W., Sinclair P.R., Shuster L., Sinclair J.F., Evans J.E., Greenblatt D.J. Norcocaine and N-hydroxynorcocaine formation in human liver microsomes: role of cytochrome P-450 3A4. Pharmacology 1993, 46:294-300.
11. Pellinen P., Honkakoski P., Stenback F., Niemitz M., Alhava E., pelkonen O., et al. Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors. Eur J Pharmacol 1994, 270:35-43.
12. Roberts S.M., Harbison R.D., James R.C. Human microsomal N-oxidative metabolism of cocaine. Drug Metab Dispos 1991, 19:1046-1051.
13. Shuster L., Casey E., Welankiwar S.S. Metabolism of cocaine and norcocaine to N-hydroxynorcocaine. Biochem Pharmacol 1983, 32:3045-3051.
14. Brewer J.D., Meves A., Bostwick J.M., Hamacher K.L., Pittelkow M.R. Cocaine abuse: dermatologic manifestations and therapeutic approaches. J Am Acad Dermatol 2008, 59:483-487.
15. Zamora-Quezada J.C., Dinerman H., Stadecker M.J., Kelly J.J. Muscle and skin infarction after free-basing cocaine (crack). Ann Intern Med 1988, 108:564-566.
16. Hofbauer G.F., Hafner J., Trueb R.M. Urticarial vasculitis following cocaine use. Br J Dermatol 1999, 141:600-601.
17. Chevalier X., Rostoker G., Larget-Piet B., Gherardi R. Schoenlein-Henoch purpura with necrotizing vasculitis after cocaine snorting. Clin Nephrol 1995, 43:348-349.
18. Abidin M.R., Gillinov M.A., Topol B.M., Francel T.J. Injection of illicit drugs into the granulation tissue of chronic ulcers. Ann Plast Surg 1990, 24:268-270.
19. Conlee R.K., Barnett D.W., Kelly K.P., Han D.H. Effects of cocaine on plasma catecholamine and muscle glycogen concentrations during exercise in the rat. J Appl Physiol 1991, 70:1323-1327.
20. Mendelson J.H., Teoh S.K., Mello N.K., Ellingboe J., Rhoades E. Acute effects of cocaine on plasma adrenocorticotropic hormone, luteinizing hormone and prolactin levels in cocaine-dependent men. J Pharmacol Exp Ther 1992, 263:505-509.
21. Portugal M., Kohen R. Peroxynitrite: a key molecule in skin tissue response to different types of stress. Oxidants in biology-a question of balance 2008, 19-36. Springer, Netherlands. J. Valacchi, P.A. Davis (Eds.).
22. Marletta M.A. Nitric oxide synthase: function and mechanism. Adv Exp Med Biol 1993, 338:281-284.
23. Nathan C., Xie Q.W. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994, 269:13725-13728.
24. Stamler J.S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994, 78:931-936.
25. Harrison R. Structure and function of xanthine oxidoreductase: where are we now?. Free Radic Biol Med 2002, 33:774-797.
26. Beckman J.S. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996, 9:836-844.
27. Richeson C., Mulder P., Bowry V., Ingold K. The complex chemistry of peroxynitrite decomposition: new insight. J Am Chem 1998, 120:7211-7219.
28. Abd-El-Aleem S.A., Ferguson M.W., Appleton I., Kairsingh S., Jude E.B., Jones K., et al. Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers. J Pathol 2000, 191:434-442.
29. Ferdinandy P. Peroxynitrite: just an oxidative/nitrosative stressor or a physiological regulator as well?. Br J Pharmacol 2006, 148:1-3.
30. Halliwell B., Gutteride J.M. Free radicals in biology and medicine 1999, Oxford University Press, Avon.
31. Kohen R., Nyska A. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 2002, 30:620-650.
32. Szabo C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 2003, 140-141:105-112.
33. Bagetta G., Piccirilli S., Del Duca C., Morrone L.A., Rombola L., Nappi G., et al. Inducible nitric oxide synthase is involved in the mechanisms of cocaine enhanced neuronal apoptosis induced by HIV-1 gp120 in the neocortex of rat. Neurosci Lett 2004, 356:183-186.
34. Elliott J.C., Ijames S.G., Lysle D.T. Cocaine increases inducible nitric oxide synthase expression in rats: effects of acute and binge administration. Int Immunopharmacol 2003, 3:1011-1018.
35. Isabelle M., Vergeade A., Moritz F., Dautreaux B., Henry J.P., Lallemand F., et al. NADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction. J Mol Cell Cardiol 2007, 42:326-332.
36. Aoki K., Ohmori M., Takimoto M., Ota H., Yoshida T. Cocaine-induced liver injury in mice is mediated by nitric oxide and reactive oxygen species. Eur J Pharmacol 1997, 336:43-49.
37. Devi B.G., Chan A.W. Cocaine-induced peroxidative stress in rat liver: antioxidant enzymes and mitochondria. J Pharmacol Exp Ther 1996, 279:359-366.
38. Wang P., Wu P., Siegel M.I., Egan R.W., Billah M.M. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 1995, 270:9558-9563.
39. Nakayama G.R., Caton M.C., Nova M.P., Parandoosh Z. Assessment of the Alamar Blue assay for cellular growth and viability in vitro. J Immunol Methods 1997, 204:205-208.
40. Koren E., Zverev I., Ginsburg I., Kohen R. Supplementation with antioxidants fails to increase the total antioxidant capacity of several cell lines in culture. Biomed Pharmacother 2008, 62:179-188.
41. Portugal-Cohen M., Kohen R. Exposure of human keratinocytes to ischemia, hyperglycemia and their combination induces oxidative stress via the enzymes inducible nitric oxide synthase and xanthine oxidase. J Dermatol Sci 2009.
42. Cao G., Verdon C.P., Wu A.H., Wang H., Prior R.L. Automated assay of oxygen radical absorbance capacity with the COBAS FARA II. Clin Chem 1995, 41:1738-1744.
43. Prior R.L., Hoang H., Gu L., Wu X., Bacchiocca M., Howard L., et al. Assays for hydrophilic and lipophilic antioxidant capacity (oxygen radical absorbance capacity (ORAC(FL))) of plasma and other biological and food samples. J Agric Food Chem 2003, 51:3273-3279.
44. Benzie I.F., Strain J.J. The ferric reducing ability of plasma (FRAP) as a measure of " antioxidant power": the FRAP assay. Anal Biochem 1996, 239:70-76.
45. Shilo S., Aronis A., Komarnitsky R., Tirosh O. Selenite sensitizes mitochondrial permeability transition pore opening in vitro and in vivo: a possible mechanism for chemo-protection. Biochem J 2003, 370:283-290.
46. Ehrman R.N., Robbins S.J., Childress A.R., O'Brien C.P. Conditioned responses to cocaine-related stimuli in cocaine abuse patients. Psychopharmacology (Berl) 1992, 107:523-529.
47. Shohami E., Gati I., Beit-Yannai E., Trembovler V., Kohen R. Closed head injury in the rat induces whole body oxidative stress: overall reducing antioxidant profile. J Neurotrauma 1999, 16:365-376.
48. Bashkatova V., Meunier J., Vanin A., Maurice T. Nitric oxide and oxidative stress in the brain of rats exposed in utero to cocaine. Ann NY Acad Sci 2006, 1074:632-642.
49. Bhargava H.N., Kumar S. Sensitization to the locomotor stimulant activity of cocaine is associated with increases in nitric oxide synthase activity in brain regions and spinal cord of mice. Pharmacology 1997, 55:292-298.
50. Toda N., Toda H., Hatano Y. Anesthetic modulation of immune reactions mediated by nitric oxide. J Anesth 2008, 22:155-162.
51. Itzhak Y. Modulation of cocaine- and methamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase. J Pharmacol Exp Ther 1997, 282:521-527.
52. Park K., Vora U., Darling S.F., Kolta M.G., Soliman K.F. The role of inducible nitric oxide synthase in cocaine-induced locomotor sensitization. Physiol Behav 2001, 74:441-447.
53. Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sci 2004, 75:639-653.
54. 2: a pulse radiolysis study. Free Radic Biol Med 1995, 19:505-510.
55. Beit-Yannai E., Kohen R., Horowitz M., Trembovler V., Shohami E. Changes of biological reducing activity in rat brain following closed head injury: a cyclic voltammetry study in normal and heat-acclimated rats. J Cereb Blood Flow Metab 1997, 17:273-279.
56. Ornoy A., Zaken V., Kohen R. Role of reactive oxygen species (ROS) in the diabetes-induced anomalies in rat embryos in vitro: reduction in antioxidant enzymes and low-molecular-weight antioxidants (LMWA) may be the causative factor for increased anomalies. Teratology 1999, 60:376-386.
57. Kohen R., Fanberstein D., Tirosh O. Reducing equivalents in the aging process. Arch Gerontol Geriatr 1997, 24:103-123.
58. Kohen R., Gati I. Skin low molecular weight antioxidants and their role in aging and in oxidative stress. Toxicology 2000, 148:149-157.
59. Ghiselli A., Serafini M., Natella F., Scaccini C. Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med 2000, 29:1106-1114.
60. Halliwell B., Whiteman M. Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?. Br J Pharmacol 2004, 142:231-255.
61. Huang D., Ou B., Prior R.L. The chemistry behind antioxidant capacity assays. J Agric Food Chem 2005, 53:1841-1856.
62. Prior R.L., Cao G. In vivo total antioxidant capacity: comparison of different analytical methods. Free Radic Biol Med 1999, 27:1173-1181.
63. Sies H. Total antioxidant capacity: appraisal of a concept. J Nutr 2007, 137:1493-1495.
64. Go Y.M., Jones D.P. Redox compartmentalization in eukaryotic cells. Biochim Biophys Acta 2008, 1780:1273-1290.
65. Meyer A.J., Hell R. Glutathione homeostasis and redox-regulation by sulfhydryl groups. Photosynth Res 2005, 86:435-457.
66. Schafer F.Q., Buettner G.R. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001, 30:1191-1212.
67. Ashton T., Young I.S., Peters J.R., Jones E., Jackson S.K., Davies B., et al. Electron spin resonance spectroscopy, exercise, and oxidative stress: an ascorbic acid intervention study. J Appl Physiol 1999, 87:2032-2036.
68. Meister A. Glutathione, ascorbate, and cellular protection. Cancer Res 1994, 54:1969s-1975s.
69. Winkler B.S., Orselli S.M., Rex T.S. The redox couple between glutathione and ascorbic acid: a chemical and physiological perspective. Free Radic Biol Med 1994, 17:333-349.
70. Janmohamed A., Dolphin C.T., Phillips I.R., Shephard E.A. Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450. Biochem Pharmacol 2001, 62:777-786.
71. Imam S.Z., Duhart H.M., Skinner J.T., Ali S.F. Cocaine induces a differential dose-dependent alteration in the expression profile of immediate early genes, transcription factors, and caspases in PC12 cells: a possible mechanism of neurotoxic damage in cocaine addiction. Ann NY Acad Sci 2005, 1053:482-490.
72. Zaragoza A., Diez-Fernandez C., Alvarez A.M., Andres D., Cascales M. Effect of N-acetylcysteine and deferoxamine on endogenous antioxidant defense system gene expression in a rat hepatocyte model of cocaine cytotoxicity. Biochim Biophys Acta 2000, 1496:183-195.
73. Oliveira M.T., Rego A.C., Morgadinho M.T., Macedo T.R., Oliveira C.R. Toxic effects of opioid and stimulant drugs on undifferentiated PC12 cells. Ann NY Acad Sci 2002, 965:487-496.
74. McCord J.M. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985, 312:159-163.
75. Engerson T.D., McKelvey T.G., Rhyne D.B., Boggio E.B., Snyder S.J., Jones H.P. Conversion of xanthine dehydrogenase to oxidase in ischemic rat tissues. J Clin Invest 1987, 79:1564-1570.
76. MacGowan S.W., Regan M.C., Malone C., Sharkey O., Young L., Gorey T.F., et al. Superoxide radical and xanthine oxidoreductase activity in the human heart during cardiac operations. Ann Thorac Surg 1995, 60:1289-1293.